Fidel Zavala Selected Research

Antigens

10/2023	Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
12/2019	Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages.
1/2016	Development and Assessment of Transgenic Rodent Parasites for the Preclinical Evaluation of Malaria Vaccines.
1/2016	Dendritic cell function and antigen presentation in malaria.
1/2014	Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities.
1/2013	Development and use of TCR transgenic mice for malaria immunology research.
5/2010	Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites.
3/2007	Viral vectors for malaria vaccine development.
2/2003	T cells as mediators of protective immunity against liver stages of Plasmodium.
9/2002	Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fidel Zavala Research Topics

Disease

59	Malaria 04/2024 - 09/2002
26	Infections 04/2024 - 12/2006
7	Parasitic Diseases (Parasitic Disease) 01/2021 - 01/2013
2	Cerebral Malaria 01/2016 - 08/2008
1	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2023
1	Neoplasms (Cancer) 01/2021
1	Hemolysis 01/2017
1	Sepsis (Septicemia) 01/2014
1	Inflammation (Inflammations) 08/2008
1	Vesicular Stomatitis 03/2007
1	Yellow Fever 03/2007

Drug/Important Bio-Agent (IBA)

33	VaccinesIBA 04/2024 - 12/2004
20	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2006
13	Monoclonal AntibodiesIBA 04/2024 - 02/2014
11	AntibodiesIBA 11/2022 - 12/2006
10	AntigensIBA 10/2023 - 09/2002
8	Malaria VaccinesIBA 03/2022 - 03/2007
8	EpitopesIBA 03/2022 - 07/2003
3	Antimalarials (Antimalarial Agents)IBA 04/2024 - 04/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2014
3	DNA VaccinesIBA 01/2022 - 04/2010
3	ChemokinesIBA 01/2021 - 08/2008
3	Subunit VaccinesIBA 01/2014 - 08/2011
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2013 - 08/2007
2	hemozoinIBA 04/2024 - 01/2023
2	Messenger RNA (mRNA)IBA 08/2023 - 12/2022
2	LipidsIBA 01/2017 - 01/2014
2	CytokinesIBA 11/2014 - 01/2014
1	A-Form DNA (A-DNA)IBA 01/2022
1	CIS43LSIBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	LigandsIBA 01/2021
1	RTS malaria vaccineIBA 01/2017
1	2-mercaptoacetate (ammonium thioglycolate)IBA 01/2017
1	EmulsionsIBA 01/2017
1	EnzymesIBA 01/2017
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	Primaquine FDA Link 01/2017
1	Chloroquine (Aralen)FDA LinkGeneric 03/2015
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2014
1	LuciferasesIBA 02/2014
1	vaxfectinIBA 01/2014
1	Poly IIBA 03/2013
1	Staphylococcal Protein A (Protein A)IBA 05/2010
1	AnthelminticsIBA 04/2010
1	Platelet Factor 4IBA 08/2008
1	tetanus toxin fragment CIBA 03/2008
1	Interleukin-7 (Interleukin 7)IBA 04/2006
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 08/2005

Therapy/Procedure

1	Therapeutics 01/2016
1	Drug Therapy (Chemotherapy) 12/2004